Livzon Pharmaceutical Covid Shot Wins China Approval
What’s new: China approved another Covid-19 vaccine for emergency use as the country continues its stringent virus-control policy with two more megacities under lockdown.
A Covid vaccine created by Livzon Pharmaceutical Group Inc. (000513.SZ) Friday became the eighth domestically developed shot approved for use in China. It will be used as a booster as nearly 90% of the country’s 1.4 billion population have received primary vaccinations.
- MOST POPULAR